Thus, our results suggest that FMT improves cardiac functions in T1D mice by reducing LAT1-driven increase in BCAA and down-regulating the mTOR/Bax/Bcl-2/caspase-3 pathway. The gene discussed is BAX; the disease is type 1 diabetes mellitus.